A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is
designed to determine the effects of BLI-1300 ointment on perianal pain associated with
active Perianal Crohn's Disease (PCD).